Bridgewater Associates’s DaVita DVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.21M | Sell |
20,902
-14,120
| -40% | -$1.92M | 0.01% | 531 |
|
|
2025
Q4 | $3.98M | Buy |
35,022
+8,218
| +31% | +$999K | 0.01% | 601 |
|
|
2025
Q3 | $3.56M | Sell |
26,804
-85,303
| -76% | -$11.7M | 0.01% | 570 |
|
|
2025
Q2 | $16M | Sell |
112,107
-116,165
| -51% | -$16.5M | 0.06% | 206 |
|
|
2025
Q1 | $34.9M | Sell |
228,272
-11,698
| -5% | -$1.84M | 0.16% | 119 |
|
|
2024
Q4 | $35.9M | Buy |
239,970
+179,744
| +298% | +$28.2M | 0.16% | 114 |
|
|
2024
Q3 | $9.87M | Sell |
60,226
-20,472
| -25% | -$3.02M | 0.06% | 263 |
|
|
2024
Q2 | $11.2M | Buy |
80,698
+21,047
| +35% | +$2.9M | 0.06% | 234 |
|
|
2024
Q1 | $8.23M | Sell |
59,651
-51,204
| -46% | -$6.14M | 0.04% | 293 |
|
|
2023
Q4 | $11.6M | Sell |
110,855
-2,213
| -2% | -$204K | 0.07% | 221 |
|
|
2023
Q3 | $10.7M | Buy |
113,068
+21,148
| +23% | +$2.16M | 0.06% | 228 |
|
|
2023
Q2 | $9.24M | Buy |
91,920
+18,171
| +25% | +$1.69M | 0.06% | 209 |
|
|
2023
Q1 | $5.98M | Sell |
73,749
-33,201
| -31% | -$2.66M | 0.04% | 284 |
|
|
2022
Q4 | $7.99M | Sell |
106,950
-182,589
| -63% | -$14.2M | 0.04% | 277 |
|
|
2022
Q3 | $24M | Buy |
289,539
+31,714
| +12% | +$2.78M | 0.12% | 137 |
|
|
2022
Q2 | $20.6M | Buy |
257,825
+139,248
| +117% | +$14.1M | 0.09% | 205 |
|
|
2022
Q1 | $13.4M | Buy |
118,577
+34,532
| +41% | +$3.88M | 0.05% | 236 |
|
|
2021
Q4 | $9.56M | Sell |
84,045
-18,439
| -18% | -$1.98M | 0.06% | 197 |
|
|
2021
Q3 | $11.9M | Buy |
102,484
+68,918
| +205% | +$8.63M | 0.07% | 178 |
|
|
2021
Q2 | $4.04M | Buy |
+33,566
| New | +$3.97M | 0.03% | 369 |
|
|
2020
Q3 | – | Sell |
-4,435
| Closed | -$351K | – | 458 |
|
|
2020
Q2 | $351K | Sell |
4,435
-2,478
| -36% | -$193K | 0.01% | 308 |
|
|
2020
Q1 | $526K | Buy |
+6,913
| New | +$543K | 0.01% | 280 |
|
|
2019
Q4 | – | Sell |
-727,788
| Closed | -$41.5M | – | 509 |
|
|
2019
Q3 | $41.5M | Buy |
727,788
+614,825
| +544% | +$35.7M | 0.36% | 28 |
|
|
2019
Q2 | $6.36M | Sell |
112,963
-315,112
| -74% | -$16.3M | 0.05% | 136 |
|
|
2019
Q1 | $23.2M | Sell |
428,075
-31,658
| -7% | -$1.75M | 0.14% | 40 |
|
|
2018
Q4 | $23.7M | Buy |
459,733
+269,579
| +142% | +$17.3M | 0.22% | 63 |
|
|
2018
Q3 | $13.6M | Buy |
+190,154
| New | +$13.4M | 0.14% | 59 |
|
|
2018
Q2 | – | Sell |
-223,124
| Closed | -$14.7M | – | 479 |
|
|
2018
Q1 | $14.7M | Buy |
+223,124
| New | +$16.4M | 0.14% | 47 |
|
|
2017
Q4 | – | Sell |
-354,456
| Closed | -$21.1M | – | 270 |
|
|
2017
Q3 | $21.1M | Buy |
354,456
+289,970
| +450% | +$17.5M | 0.14% | 29 |
|
|
2017
Q2 | $4.18M | Sell |
64,486
-77,818
| -55% | -$5.15M | 0.04% | 110 |
|
|
2017
Q1 | $9.67M | Buy |
142,304
+54,060
| +61% | +$3.58M | 0.11% | 56 |
|
|
2016
Q4 | $5.67M | Buy |
88,244
+22,944
| +35% | +$1.43M | 0.05% | 129 |
|
|
2016
Q3 | $4.31M | Sell |
65,300
-10,670
| -14% | -$751K | 0.04% | 131 |
|
|
2016
Q2 | $5.87M | Buy |
75,970
+69,370
| +1,051% | +$5.24M | 0.07% | 108 |
|
|
2016
Q1 | $484K | Sell |
6,600
-25,345
| -79% | -$1.71M | 0.01% | 241 |
|
|
2015
Q4 | $2.23M | Buy |
+31,945
| New | +$2.34M | 0.03% | 175 |
|
|
2015
Q3 | – | Sell |
-79,526
| Closed | -$6.32M | – | 455 |
|
|
2015
Q2 | $6.32M | Buy |
79,526
+24,200
| +44% | +$1.99M | 0.06% | 83 |
|
|
2015
Q1 | $4.5M | Buy |
55,326
+5,300
| +11% | +$407K | 0.04% | 134 |
|
|
2014
Q4 | $3.79M | Buy |
50,026
+23,500
| +89% | +$1.77M | 0.03% | 136 |
|
|
2014
Q3 | $1.94M | Sell |
26,526
-4,572
| -15% | -$335K | 0.02% | 171 |
|
|
2014
Q2 | $2.25M | Sell |
31,098
-33,843
| -52% | -$2.35M | 0.02% | 169 |
|
|
2014
Q1 | $4.47M | Sell |
64,941
-28,496
| -30% | -$1.89M | 0.04% | 113 |
|
|
2013
Q4 | $5.92M | Buy |
93,437
+4,037
| +5% | +$237K | 0.05% | 90 |
|
|
2013
Q3 | $5.09M | Buy |
89,400
+66,600
| +292% | +$3.82M | 0.04% | 89 |
|
|
2013
Q2 | $1.38M | Buy |
+22,800
| New | +$1.42M | 0.01% | 174 |
|
Other funds holding DVA
VCM
VPM
Bridgewater Associates's DVA Position: Q1 2026 in Review
Bridgewater Associates reduced its DaVita (DVA) stake by 40% in Q1 2026, selling an estimated $1.92M and leaving 20,902 shares worth $3.21M. The position accounts for 0.01% of the portfolio, ranked #531.
Bridgewater Associates first reported a position in DVA in Q2 2013 and has held it in 45 quarters since. The position peaked at $41.5M in Q3 2019. 582 funds tracked by Wall St. Rank hold DVA as of Q1 2026.
- Bridgewater Associates held 20,902 shares of DaVita worth $3.21M as of Q1 2026.
- Bridgewater Associates sold 14,120 DaVita shares in Q1 2026, an estimated $1.92M.
- DaVita made up 0.01% of Bridgewater Associates's portfolio in Q1 2026, its #531 holding.
- Bridgewater Associates first reported a position in DaVita in Q2 2013 and has held it in 45 quarters since.
- Bridgewater Associates's DaVita position peaked at $41.5M in Q3 2019.
- 582 funds tracked by Wall St. Rank held DaVita as of Q1 2026.
Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.